Stay updated on ELOQUENT-3 Clinical Trial

Sign up to get notified when there's something new on the ELOQUENT-3 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ELOQUENT-3 Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.5.2 was added and Revision: v3.5.0 was removed from the history.
    Difference
    0.0%
    Check dated 2026-04-16T11:17:16.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    41 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3 in the record history.
    Difference
    0.0%
    Check dated 2026-03-18T19:36:39.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T17:11:46.000Z thumbnail image
  6. Check
    76 days ago
    Change Detected
    Summary
    A new revision entry (v3.4.2) was added and the prior funding/operating-status disclaimer (v3.4.1) was removed; these are maintenance updates with no impact on study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T10:31:11.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    A global notice about government funding lapse and operating status was added. The page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T06:34:51.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    The history page now includes a glossary display toggle, green/red highlights to indicate additions and deletions, and an updated revision line from v3.3.4 to v3.4.0.
    Difference
    0.5%
    Check dated 2026-01-28T04:40:00.000Z thumbnail image

Stay in the know with updates to ELOQUENT-3 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ELOQUENT-3 Clinical Trial page.